HES6 and prostate adenocarcinoma: HES6 is highly expressed in metastatic prostate adenocarcinomas and required for the hypoxia-mediated neuroendocrine phenotype, the metastasis of prostate adenocarcinomas, and the formation of neuroendocrine tumors (Qi et al., 2010).